Keratin-Positive Giant Cell Tumor of Bone and Soft Tissue With HMGA2::NCOR2 Fusion in Children Under 10 With Response to Imatinib Therapy: A Case Series

Affiliations

• ¹ Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA.
• ² Department of Hematology, Oncology and Bone Marrow Transplant, Perth Children's Hospital, Nedlands, Australia.
• ³ Telethon Kids Insitute, University of Western Australia, Nedlands, Australia.
• ⁴ PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, Australia.
• ⁵ Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
• ⁶ Division of Pediatric Otolaryngology, Children's Hospital of Philadelphia, Philadelphia, PA.
• ⁷ Department of Otorhinolaryngology/Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA.
• ⁸ Division of Orthopedic Surgery, Children's Hospital of Philadelphia, Philadelphia, PA.
• ⁹ Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, Australia.
• ¹⁰ School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, Australia.
• ¹¹ Broad Institute of MIT and Harvard, Boston, MA.
• ¹² Department of Laboratories, Seattle Children's Hospital, Seattle, WA.
• ¹³ Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA.
• ¹⁴ Department of Medical Imaging, Perth Children's Hospital, Nedlands, Australia.
• ¹⁵ Division of Pediatrics, Medical School, University of Western Australia, Crawley, Australia.
• ¹⁶ PathWest Laboratory Medicine, Perth Children's Hospital, Nedlands, WA, Australia.